Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice

Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of chronic liver disease. NAFLD begins with excessive lipid accumulation in the liver and progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is closely linked to dysregulated hepatic lipid metabolism. Although re...

Descripción completa

Detalles Bibliográficos
Autores principales: Choung, Sorim, Kim, Ji Min, Joung, Kyong Hye, Lee, Eaum Seok, Kim, Hyun Jin, Ku, Bon Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368280/
https://www.ncbi.nlm.nih.gov/pubmed/30735525
http://dx.doi.org/10.1371/journal.pone.0210828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368280/
https://www.ncbi.nlm.nih.gov/pubmed/30735525
http://dx.doi.org/10.1371/journal.pone.0210828

Ejemplares similares